Overview

Obtaining market approvals in Egypt would require compliance with the regulations of Central Administration of Pharmaceutical Affairs (CAPA), a division of the Egyptian Ministry of Health. To navigate through the registration and approval procedures, manufacturers should require an authorized representative in the region besides being updated with the region’s Regulatory requirements.

Freyr’s Regulatory consulting for Egypt includes strategic advice on Regulatory submissions for:

Freyr Offerings

  • Strategic Regulatory Consulting
  • Health Authority interactions
  • Registration and license management services
  • Dossier management
  • End-to-end Regulatory submissions
  • Regulatory labeling and artwork services
  • MOH follow-up

Freyr Advantages

  • Strategic and well-versed local regulatory knowledgebase – with Ministry of Health
  • Expert Regulatory team with proven track records
  • Proactive and Collaborative approach
  • Quick turnarounds and faster time-to-market
  • Keeping abreast with region-specific legislation and Regulatory guidelines